Johansson; Par

Patent Applications and Registrations

Patent applications and USPTO patent grants for Johansson; Par.The latest application filed is for "methods and systems for application of wax on geophysical streamers".

Company Profile

0.9.16

Johansson; Par - Trollhattan SE
Johansson; Par - Hjo SE
Johansson; Par - Dosjebro SE
Johansson; Par - Vastra Frolunda N/A SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and Systems for Application of Wax on Geophysical Streamers App 20180321032 - Vasbo; Christian ; et al.	2018-11-08
Method and system for detecting urine and/or feces Grant 9,927,410 - Carney , et al. March 27, 2	2018-03-27
Injectable Pharmaceutical Compositions Comprising Prostacyclin App 20160303040 - Johansson; Par ; et al.	2016-10-20
Injectable pharmaceutical compositions comprising adrenaline and citric acid Grant 9,433,589 - Hansen , et al. September 6, 2	2016-09-06
Systemic Pro-hemostatic Effect Of Sympathicomimetics With Agonistic Effects On Alfa-adrenergic And/or Beta-adrenergic Receptors Of The Sympathetic Nervous System, Related To Improved Clot Strength App 20160250164 - Johansson; Par ; et al.	2016-09-01
Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof Grant 9,381,243 - Johansson , et al. July 5, 2	2016-07-05
Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength Grant 9,381,166 - Johansson , et al. July 5, 2	2016-07-05
Injectable Pharmaceutical Compositions Comprising Adrenaline And Citric Acid App 20160113891 - Hansen; Philip ; et al.	2016-04-28
Method And System For Detecting Urine And/or Feces App 20150330958 - CARNEY; Joshua ; et al.	2015-11-19
Compounds Capable Of Modulating/preserving Endothelial Integrity For Use In Prevention Or Treatment Of Acute Traumatic Coagulopathy And Resuscitated Cardiac Arrest App 20150057325 - Johansson; Par ; et al.	2015-02-26
Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof Grant 8,877,710 - Johansson , et al. November 4, 2	2014-11-04
Methods Of Identifying Critically Ill Patients At Increased Risk Of Development Of Organ Failure And Compounds For The Treatment Hereof App 20140322207 - Johansson; Par ; et al.	2014-10-30
Prostacyclin And Analogs Thereof Administered During Surgery For Prevention And Treatment Of Capillary Leakage App 20140044797 - Johansson; Par ; et al.	2014-02-13
Compounds Capable Of Modulating/preserving Endothelial Integrity For Use In Prevention Or Treatment Of Acute Traumatic Coagulopathy And Resuscitated Cardiac Arrest App 20130261177 - Johansson; Par ; et al.	2013-10-03
Method for reducing signalling Grant 8,428,589 - Hjelmgren , et al. April 23, 2	2013-04-23
Methods Of Treatment Of Patients At Increased Risk Of Development Of Ischemic Events And Compounds Hereof App 20130040898 - Johansson; Par	2013-02-14
Method For Reducing Signalling App 20120329458 - HJELMGREN; Klas ; et al.	2012-12-27
Methods Of Identifying Critically Ill Patients At Increased Risk Of Development Of Organ Failure And Compounds For The Treatment Hereof App 20110268732 - Johansson; Par	2011-11-03
Systemic Pro-hemostatic Effect of Sympathicomimetics with Agonistic Effects on Alfa-Adrenergic and/or Beta-Adrenergic Receptors of the Sympathetic Nervous System, Related to Improved Clot Strength App 20110201553 - Johansson; Par ; et al.	2011-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.